"Fox Insight is an online clinical study that collects self-reported data about health experiences from those with and without Parkinson’s, and aims to transform the search for better treatments for the disease. 23andMe and The Michael J. Fox Foundation have joined forces to help eligible participants add their genetic data to this study, which can allow researchers to create a more holistic understanding of the disease. This folds neatly into 23andMe’s long-standing goals of better understanding, treating and preventing the disease.
"In the last year, Fox Insight enrollment has more than quadrupled to over 27,000 people and counting, and we hope that thousands, even hundreds of thousands, more will participate.
"To educate people about genetic research and how it could help us overcome knowledge and treatment gaps in Parkinson’s, MJFF created a new video to explain what genetics is teaching us about the disease. As movement disorder specialist and Michael J. Fox Foundation Scientific Advisor Dr. Susan Bressman puts it,
'Advances coming out of genetic research today offer one of our best chances to develop drugs that will help everyone living with Parkinson’s whether they have a (genetic) mutation (for the disease) or not.'
"That’s because insights from genetic research can help scientists better understand how Parkinson’s develops, why it manifests itself differently in some people, and why some individuals who carry a genetic mutation associated with Parkinson’s never develop the disease. Studying both those with and without Parkinson’s illuminates these questions. Take a moment to check out the video and learn more about Fox Insight."
Full '23andMe' Blog Post: blog.23andme.com/research-c...
Fox Insight: foxinsight.michaeljfox.org/
Parkinson's research journal club on Twitter?
Impact of Parkinson's
To speed up research and trials, we require financial support 
